PortfoliosLab logoPortfoliosLab logo
ATAI vs. SGMO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ATAI vs. SGMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Atai Life Sciences N.V. (ATAI) and Sangamo Therapeutics, Inc. (SGMO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ATAI

1D
0.00%
1M
38.34%
6M
90.96%
YTD
75.55%
1Y
72.18%
3Y*
51.86%
5Y*
-14.26%
10Y*
ALL TIME*
-18.92%

SGMO

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$95.05M$137.83M$67.37M

ATAI vs. SGMO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ATAI
Atai Life Sciences N.V.
75.55%207.52%-5.67%-46.99%-65.14%-63.67%
SGMO
Sangamo Therapeutics, Inc.
-82.38%-58.82%87.74%-82.70%-58.13%-34.50%

Correlation

The correlation between ATAI and SGMO is 0.26, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.26

Correlation (3Y)
Balances recent behavior with more history.

0.27

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.35

Correlation (All Time)
Calculated using the full available price history since Jun 18, 2021

0.35

Fundamentals

Market Cap

ATAI:

$2.66B

SGMO:

$30.66M

EPS

ATAI:

-$2.50

SGMO:

-$0.36

PS Ratio

ATAI:

546.93

SGMO:

0.74

Total Revenue (TTM)

ATAI:

$3.49M

SGMO:

$34.56M

Gross Profit (TTM)

ATAI:

$3.49M

SGMO:

$25.51M

EBITDA (TTM)

ATAI:

-$663.38M

SGMO:

-$106.29M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ATAI vs. SGMO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ATAI
ATAI Risk / Return Rank: 7474
Overall Rank
ATAI Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
ATAI Sortino Ratio Rank: 7979
Sortino Ratio Rank
ATAI Omega Ratio Rank: 7676
Omega Ratio Rank
ATAI Calmar Ratio Rank: 7474
Calmar Ratio Rank
ATAI Martin Ratio Rank: 6868
Martin Ratio Rank

SGMO

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ATAI vs. SGMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ATAISGMODifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.23

Calmar ratioReturn relative to maximum drawdown

1.57

Martin ratioReturn relative to average drawdown

2.43

ATAI vs. SGMO - Sharpe Ratio Comparison


Loading charts...

Drawdowns

ATAI vs. SGMO - Drawdown Comparison


Loading charts...

Drawdown Indicators


ATAISGMODifference

Max Drawdown

Largest peak-to-trough decline

-95.05%

Max Drawdown (1Y)

Largest decline over 1 year

-48.06%

Max Drawdown (3Y)

Largest decline over 3 years

-59.23%

Max Drawdown (5Y)

Largest decline over 5 years

-94.17%

Current Drawdown

Current decline from peak

-65.81%

Average Drawdown

Average peak-to-trough decline

-80.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.99%

Volatility

ATAI vs. SGMO - Volatility Comparison


Loading charts...

Volatility by Period


ATAISGMODifference

Volatility (1M)

Calculated over the trailing 1-month period

33.68%

Volatility (6M)

Calculated over the trailing 6-month period

61.09%

Volatility (1Y)

Calculated over the trailing 1-year period

82.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.88%

Dividends

ATAI vs. SGMO - Dividend Comparison

Neither ATAI nor SGMO has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ATAI vs. SGMO - Financials Comparison

This section allows you to compare key financial metrics between Atai Life Sciences N.V. and Sangamo Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ATAI and SGMO have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ATAI and SGMO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer